NOUVELLES FORMES CRISTALLINES D'IBRUTINIB
- 专利权人:
- Apotex Inc.
- 发明人:
- 申请号：
- EP18175331.0
- 公开号：
- EP3575300A1
- 申请日:
- 2018.05.31
- 申请国别(地区):
- EP
- 年份:
- 2019
- 代理人:
- 摘要：
- The present invention provides novel crystalline forms of Ibrutinib. Specific crystalline forms provided by the present invention include Ibrutinib Form APO-I, an anhydrous form； APO-II, a methyl benzoate solvate of Ibrutinib； and APO-IV, a methyl salicylate solvate of Ibrutinib.
- 来源网站：
- 中国工程科技知识中心
